Database for metabolic surgery outcomes at Beijing Friendship Hospital
Official title: Beijing Friendship Hospital Metabolic Surgery Clinical Database
Run by Beijing Friendship Hospital · NCT03520699 · Data updated 2026-11-12
This study is collecting information from patients who have had metabolic surgery at Beijing Friendship Hospital to see how well it works for treating obesity-related health issues like type 2 diabetes and high blood pressure.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Beijing Friendship Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | December 1, 2017 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | September 10, 2019 |
| Trial ID | NCT03520699 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are severely obese patients who are eligible for metabolic surgery, such as laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB).
✕Probably not a fit
Patients who cannot understand or are unwilling to participate in the registry will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect and analyze data from patients undergoing metabolic surgery at Beijing Friendship Hospital. It focuses on understanding the efficacy and safety of metabolic surgery in treating obesity-related metabolic diseases, such as type 2 diabetes and hypertension, among Chinese patients. By gathering a larger sample size and extending the observation period, the study seeks to provide valuable insights into the long-term benefits of metabolic surgery. The findings may help inform future research and clinical practices in this field.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of metabolic surgery's effectiveness in improving health outcomes for obese patients.
How similar studies have gone: Other studies have shown promising results regarding the efficacy of metabolic surgery in treating obesity-related conditions, indicating that this approach is supported by existing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * be able to receive metabolic surgery (LSG or LRYGB) Exclusion Criteria: * can not be able to understand and willing to participate in this registry with signature
Where it's running
-
Beijing Friendship Hospital
Beijing, China Recruiting
Study contacts
- Principal investigator: Zhongtao Zhang, M.D. — Beijing Friendship Hospital
- Study coordinator: Zhongtao Zhang, M.D.
- Email: zhangzht@ccmu.edu.cn
- Phone: +86-13801060364
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Efsubaglutide alfa for weight loss after metabolic surgery
This trial will test whether efsubaglutide alfa helps people who remain obese six months after metabolic surgery lose weight and improve obesity-related health problems.
-
Comparing conventional and tailored limb lengths in gastric bypass surgery
This study is testing whether customizing the lengths of certain parts of gastric bypass surgery can help people lose more weight and improve their health compared to standard lengths.
-
Database for studying obesity and metabolic surgery outcomes in China
This study is collecting information from people in China who have obesity and are having weight loss surgery to see how well these surgeries work in the long run.
-
Long-term outcomes of laparoscopic gastric sleeve surgery
This study looks at how people with severe obesity do five years after having laparoscopic gastric sleeve surgery, focusing on their weight loss, health issues related to obesity, and any nutritional problems they might face.
-
Collagen Supplements After Sleeve Gastrectomy
This observational study looks to see if taking collagen-containing supplements after sleeve gastrectomy affects muscle mass, body composition, and body image in adults who had bariatric surgery.
-
Early reinitiation of semaglutide after sleeve gastrectomy in youth
In youths aged 12–18 with severe obesity who had sleeve gastrectomy and were taking semaglutide, this study tests whether restarting semaglutide two weeks after surgery for 24 months leads to better weight and metabolic outcomes than standard care without drugs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.